Last $5.53 USD
Change Today -0.41 / -6.90%
Volume 629.8K
IDIX On Other Exchanges
IDIX is not on other exchanges.
As of 5:20 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald C. Renaud Jr.

Chief Executive Officer, President and Director, Idenix Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 27 board members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2012


Mr. Ronald C. Renaud, Jr., has been the Chief Executive Officer and President of Idenix Pharmaceuticals Inc. since October 28, 2010. Mr. Renaud has been Principal and Equity Research Analyst of SoundView Technology Group Inc. since September 2003. Mr. Renaud served as the Chief Financial Officer of Idenix Pharmaceuticals Inc., from June 29, 2007 to October 28, 2010, its Chief Business Officer from June 2010 to October 28, 2010, and also served as its Principal Accounting ...

Read Full Background

Corporate Headquarters*

320 Bent Street
Cambridge, Massachusetts 02141

United States

Phone: 617-995-9800
Fax: 617-995-9801

Board Members Memberships*

Chief Executive Officer, President and Director


University of Southern California, Marshall School of Business
Saint Anselm College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$500,961

Stock Options*

All Other Compensation$16,190
Exercised Options74,990
Exercised Options Value$186,223
Exercisable Options841,260
Exercisable Options Value$413,688
Unexercisable Options613,750
Unexercisable Options Value$393,187
Total Value of Options$993,097
Total Number of Options1,530,000

Total Compensation*

Total Annual Cash Compensation$749,151
Total Short Term Compensation$500,961
Other Long Term Compensation$16,190
Total Calculated Compensation$3,643,214
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDIX:US $5.53 USD -0.41


Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDENIX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at